Skip to content
10-Q

Quarterly Report

Oric Pharmaceuticals, Inc. ORIC

0001193125-25-280234

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 5, 2025 97.39M sh
Shares Diluted Q3 2025 · Sep 30, 2025 98.95M sh
Shares Diluted Q3 2025 · Sep 30, 2025 82.81M sh
Shares Diluted Q3 2025 · Sep 30, 2024 70.54M sh
Shares Diluted Q3 2025 · Sep 30, 2024 69.42M sh
Capex Q3 2025 · Sep 30, 2025 $485K
Capex Q3 2025 · Sep 30, 2024 $969K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$88.49M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$84.61M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $49.67M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $59.41M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $44.23M
Stockholders Equity Q3 2025 · Sep 30, 2025 $406.92M
Stockholders Equity Q3 2025 · Jun 30, 2025 $324M
Stockholders Equity Q3 2025 · Mar 31, 2025 $219.74M
Stockholders Equity Q3 2025 · Dec 31, 2024 $243.12M
Stockholders Equity Q3 2025 · Sep 30, 2024 $273.99M
Stockholders Equity Q3 2025 · Jun 30, 2024 $302.4M
Stockholders Equity Q3 2025 · Mar 31, 2024 $328.65M
Stockholders Equity Q3 2025 · Dec 31, 2023 $224.09M
Current Liabilities Q3 2025 · Sep 30, 2025 $20.18M
Current Liabilities Q3 2025 · Dec 31, 2024 $24.85M
Total Liabilities Q3 2025 · Sep 30, 2025 $24.27M
Total Liabilities Q3 2025 · Dec 31, 2024 $31.02M
Current Assets Q3 2025 · Sep 30, 2025 $295.59M
Current Assets Q3 2025 · Dec 31, 2024 $262.25M
Total Assets Q3 2025 · Sep 30, 2025 $431.19M
Total Assets Q3 2025 · Dec 31, 2024 $274.14M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.33
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.20
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.49
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.32
Eps Basic Q3 2025 · Sep 30, 2025 −$0.33
Eps Basic Q3 2025 · Sep 30, 2025 −$1.20
Eps Basic Q3 2025 · Sep 30, 2024 −$0.49
Eps Basic Q3 2025 · Sep 30, 2024 −$1.32
Sga Expense Q3 2025 · Sep 30, 2025 $7.9M
Sga Expense Q3 2025 · Sep 30, 2025 $24.49M
Sga Expense Q3 2025 · Sep 30, 2024 $7.12M
Sga Expense Q3 2025 · Sep 30, 2024 $21.22M
Net Income Q3 2025 · Sep 30, 2025 −$32.59M
Net Income Q3 2025 · Sep 30, 2025 −$98.96M
Net Income Q3 2025 · Sep 30, 2024 −$34.57M
Net Income Q3 2025 · Sep 30, 2024 −$91.54M
Operating Income Q3 2025 · Sep 30, 2025 −$36.67M
Operating Income Q3 2025 · Sep 30, 2025 −$108.45M
Operating Income Q3 2025 · Sep 30, 2024 −$38.32M
Operating Income Q3 2025 · Sep 30, 2024 −$103.33M